Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
14.51
-0.22 (-1.49%)
At close: Jun 20, 2025, 4:00 PM
14.49
-0.02 (-0.14%)
After-hours: Jun 20, 2025, 4:11 PM EDT
Sionna Therapeutics Market Cap
Sionna Therapeutics has a market cap or net worth of $638.89 million as of June 20, 2025.
Market Cap
638.89M
Enterprise Value
293.70M
1-Year Change
n/a
Ranking
Category
Stock Price
14.51
Market Cap Chart
Since the IPO on February 7, 2025, Sionna Therapeutics's market cap has decreased from $733.61M to $638.89M, a decrease of -12.91%. That is a compound annual growth rate of -31.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 18, 2025 | 649.48M | 6.35% |
Jun 17, 2025 | 610.68M | -3.21% |
Jun 16, 2025 | 630.96M | -12.64% |
Jun 13, 2025 | 722.23M | -3.59% |
Jun 12, 2025 | 749.13M | -1.56% |
Jun 11, 2025 | 761.03M | -5.48% |
Jun 10, 2025 | 805.12M | 10.94% |
Jun 9, 2025 | 725.76M | -4.41% |
Jun 6, 2025 | 759.27M | 7.42% |
Jun 5, 2025 | 706.80M | 1.46% |
Jun 4, 2025 | 696.66M | 9.12% |
Jun 3, 2025 | 638.45M | 3.65% |
Jun 2, 2025 | 615.97M | 2.05% |
May 30, 2025 | 603.62M | -2.98% |
May 29, 2025 | 622.14M | 10.84% |
May 28, 2025 | 561.29M | -2.68% |
May 27, 2025 | 576.72M | 2.83% |
May 23, 2025 | 560.85M | -2.23% |
May 22, 2025 | 573.64M | -3.63% |
May 21, 2025 | 595.24M | -3.64% |
May 20, 2025 | 617.73M | -3.45% |
May 19, 2025 | 639.78M | 8.04% |
May 16, 2025 | 592.16M | -0.07% |
May 15, 2025 | 592.60M | 12.00% |
May 14, 2025 | 529.11M | -6.43% |
May 13, 2025 | 565.48M | -0.58% |
May 12, 2025 | 568.79M | 4.63% |
May 9, 2025 | 543.61M | -1.99% |
May 8, 2025 | 554.64M | -2.41% |
May 7, 2025 | 568.32M | 0.94% |
May 6, 2025 | 563.03M | -0.23% |
May 5, 2025 | 564.35M | -5.82% |
May 2, 2025 | 599.21M | 5.27% |
May 1, 2025 | 569.20M | 7.23% |
Apr 30, 2025 | 530.82M | -0.08% |
Apr 29, 2025 | 531.26M | - |
Apr 28, 2025 | 531.26M | -0.82% |
Apr 25, 2025 | 535.67M | -3.65% |
Apr 24, 2025 | 555.97M | -3.74% |
Apr 23, 2025 | 577.59M | 9.72% |
Apr 22, 2025 | 526.40M | 5.58% |
Apr 21, 2025 | 498.61M | 2.08% |
Apr 17, 2025 | 488.46M | 10.70% |
Apr 16, 2025 | 441.24M | 5.04% |
Apr 15, 2025 | 420.06M | 6.85% |
Apr 14, 2025 | 393.15M | 13.21% |
Apr 11, 2025 | 347.26M | 2.74% |
Apr 10, 2025 | 337.99M | -13.74% |
Apr 9, 2025 | 391.82M | -0.78% |
Apr 8, 2025 | 394.91M | -8.02% |
Apr 7, 2025 | 429.33M | -2.41% |
Apr 4, 2025 | 439.92M | -14.13% |
Apr 3, 2025 | 512.28M | -1.86% |
Apr 2, 2025 | 521.99M | 16.44% |
Apr 1, 2025 | 448.30M | -2.87% |
Mar 31, 2025 | 461.54M | -9.52% |
Mar 28, 2025 | 510.08M | -3.51% |
Mar 27, 2025 | 528.61M | -0.50% |
Mar 26, 2025 | 531.26M | -6.88% |
Mar 25, 2025 | 570.53M | 6.86% |
Mar 24, 2025 | 533.91M | -11.61% |
Mar 21, 2025 | 604.06M | -1.37% |
Mar 20, 2025 | 612.45M | 0.04% |
Mar 19, 2025 | 612.23M | -3.14% |
Mar 18, 2025 | 632.08M | -3.76% |
Mar 17, 2025 | 656.78M | -0.60% |
Mar 14, 2025 | 660.75M | -12.40% |
Mar 13, 2025 | 754.26M | -0.06% |
Mar 12, 2025 | 754.70M | 5.29% |
Mar 11, 2025 | 716.77M | 9.06% |
Mar 10, 2025 | 657.22M | -8.42% |
Mar 7, 2025 | 717.65M | 3.96% |
Mar 6, 2025 | 690.30M | -5.04% |
Mar 5, 2025 | 726.92M | 11.35% |
Mar 4, 2025 | 652.81M | 2.71% |
Mar 3, 2025 | 635.61M | 4.65% |
Feb 28, 2025 | 607.38M | -6.71% |
Feb 27, 2025 | 651.05M | -4.90% |
Feb 26, 2025 | 684.57M | -9.08% |
Feb 25, 2025 | 752.94M | -13.37% |
Feb 24, 2025 | 869.17M | -0.28% |
Feb 21, 2025 | 871.59M | -1.72% |
Feb 20, 2025 | 886.81M | 0.63% |
Feb 19, 2025 | 881.30M | -0.30% |
Feb 18, 2025 | 883.94M | 0.05% |
Feb 14, 2025 | 883.50M | -1.23% |
Feb 13, 2025 | 894.53M | 2.11% |
Feb 12, 2025 | 876.00M | -2.69% |
Feb 11, 2025 | 900.26M | -8.23% |
Feb 10, 2025 | 980.98M | 33.72% |
Feb 7, 2025 | 733.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 710.32B |
Johnson & Johnson | 366.64B |
Novo Nordisk | 334.60B |
AbbVie | 327.63B |
UnitedHealth Group | 280.19B |
Abbott Laboratories | 230.15B |
Novartis AG | 229.92B |
AstraZeneca | 223.18B |